Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Dec;61(6):1033-43.
doi: 10.1016/j.jaad.2009.03.048.

Pain associated with aminolevulinic acid-photodynamic therapy of skin disease

Christine B Warren  1 , Laszlo J Karai, Allison Vidimos, Edward V Maytin
Affiliations
Review

Pain associated with aminolevulinic acid-photodynamic therapy of skin disease

Christine B Warren et al. J Am Acad Dermatol. 2009 Dec.

Abstract

Background: Pain during topical aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) limits the use of this treatment of skin diseases.

Objective: We sought to summarize the effectiveness of interventions to reduce ALA-PDT-related pain, and to explore factors contributing to pain induction.

Methods: A PubMed search was performed to identify all clinical PDT trials (2000-2008) that used ALA or methyl-ALA, enrolled at least 10 patients per trial, and used a semiquantitative pain scale.

Results: In all, 43 articles were identified for review. Pain intensity is associated with lesion size and location and can be severe for certain diagnoses, such as plaque-type psoriasis. Results are inconsistent for the correlation of pain with light source, wavelength of light, fluence rate, and total light dose. Cooling represents the best topical intervention.

Limitations: Pain perception differs widely between patients and can contribute to variability in the reported results.

Conclusion: Gamma-aminobutyric acid receptors, cold/menthol receptors (transient receptor potential cation channel, subfamily M, member 8), and vanilloid/capsaicin receptors (transient receptor potential cation channel, subfamily V, member 1) may be involved in pain perception during ALA-PDT and are therefore worthy of further investigation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: The authors have no conflict of interest to declare.

References

    1. Hasan T, Ortel B, Solban N, Pogue B. Photodynamic therapy of cancer. In: Kufe DBR, Hait W, et al., editors. Cancer Medicine. 7th edn. Hamilton, Ontario: BC Decker, Inc.; 2006. pp. 537–548.
    1. Thunell S, Harper P, Brun A. Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest. 2000;60:581–604. - PubMed
    1. Wennberg AM. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol. 2005;(46 Suppl):S3–S4. discussion S23–5. - PubMed
    1. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–497. - PubMed
    1. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19:134–141. - PubMed

Publication types

MeSH terms

Substances